4//SEC Filing
KOCH KEVIN 4
Accession 0001562180-25-003658
CIK 0001710072other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 9:10 PM ET
Size
12.7 KB
Accession
0001562180-25-003658
Insider Transaction Report
Form 4
KOCH KEVIN
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-05-01+10,417→ 24,895 total - Sale
Common Stock
2025-05-02$16.45/sh−4,276$70,358→ 20,619 total - Exercise/Conversion
Restricted Stock Units
2025-05-01−10,417→ 0 totalExercise: $0.00From: 2025-05-01Exp: 2032-05-01→ Common Stock (10,417 underlying)
Holdings
- 26,410(indirect: By Trust)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
- 26,410(indirect: See Footnotes)
Common Stock
- 26,410(indirect: By Trust)
Common Stock
- 259,554(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001185829
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 9:10 PM ET
- Size
- 12.7 KB